• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手部湿疹严重程度指数的反应性与可解释性。

Responsiveness and interpretability of the Hand Eczema Severity Index.

作者信息

Oosterhaven J A F, Schuttelaar M L A

机构信息

Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

出版信息

Br J Dermatol. 2020 Apr;182(4):932-939. doi: 10.1111/bjd.18295. Epub 2019 Sep 5.

DOI:10.1111/bjd.18295
PMID:31260086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7186841/
Abstract

BACKGROUND

The Hand Eczema Severity Index (HECSI) is used to measure the severity of hand eczema. It is unclear what HECSI scores mean and what is the minimally important change (MIC). Furthermore, its responsiveness has not been studied.

OBJECTIVES

To study the responsiveness and interpretability of the HECSI.

METHODS

This was a prospective study covering two time points: baseline and after 4-12 weeks. Responsiveness was assessed using a criterion approach, with at least one-step improvement on the 'Photographic guide for severity of hand eczema' as the anchor for important improvement. Interpretability of single scores was determined by defining severity bands based on agreement with the anchor. For change scores, the smallest detectable change (SDC) was calculated in patients indicating no change and the MIC was obtained in patients indicating that they had changed using three methods: mean cutoff, receiver operating characteristic (ROC) curve and 95% limit.

RESULTS

In total, 294 patients participated (160 male, mean age 44·9 years). HECSI scores improved or deteriorated in parallel with the anchor. The area under the ROC curve was 0·86 (95% confidence interval 0·81-0·91). The final severity band for single scores had a κ-coefficient of agreement of 0·694: clear, 0; almost clear, 1-16; moderate, 17-37; severe, 38-116; very severe, ≥ 117. The SDC in 93 unchanged patients was 40·3 points. The obtained MIC values were all smaller than the SDC.

CONCLUSIONS

The HECSI has good responsiveness. This study gives meaning to HECSI scores, which can be applied to clinical decision making and the design of clinical trials. We recommend that an improvement of 41 points on the HECSI is regarded as the minimally measurable true change. What's already known about this topic? The Hand Eczema Severity Index (HECSI) is one of the most widely used measurement instruments to measure the severity of hand eczema. The HECSI has good reliability, but its responsiveness and interpretability have not been studied. What does this study add? This study shows good responsiveness of the HECSI. A severity grading for single scores is proposed. The smallest detectable change and minimally important change for improvement are determined. What are the clinical implications of this work? The obtained values help to interpret HECSI scores in daily practice and clinical studies, and may facilitate researchers in the calculation of sample sizes for clinical trials.

摘要

背景

手部湿疹严重程度指数(HECSI)用于衡量手部湿疹的严重程度。目前尚不清楚HECSI评分的意义以及最小重要变化(MIC)是什么。此外,其反应性尚未得到研究。

目的

研究HECSI的反应性和可解释性。

方法

这是一项前瞻性研究,涵盖两个时间点:基线和4-12周后。使用标准方法评估反应性,以“手部湿疹严重程度摄影指南”上至少有一步改善作为重要改善的锚定。通过根据与锚定的一致性定义严重程度带,确定单个评分的可解释性。对于变化评分,在表示无变化的患者中计算最小可检测变化(SDC),并在表示有变化的患者中使用三种方法获得MIC:平均截断值、受试者操作特征(ROC)曲线和95%界限。

结果

共有294例患者参与(160例男性,平均年龄44.9岁)。HECSI评分与锚定平行改善或恶化。ROC曲线下面积为0.86(95%置信区间0.81-0.91)。单个评分的最终严重程度带的κ一致性系数为0.694:清晰,0;几乎清晰,1-16;中度,17-37;重度,38-116;极重度,≥117。93例无变化患者的SDC为40.3分。获得的MIC值均小于SDC。

结论

HECSI具有良好的反应性。本研究赋予了HECSI评分意义,可应用于临床决策和临床试验设计。我们建议将HECSI提高41分视为最小可测量的真实变化。关于该主题已知的信息有哪些?手部湿疹严重程度指数(HECSI)是测量手部湿疹严重程度最广泛使用的测量工具之一。HECSI具有良好的可靠性,但其反应性和可解释性尚未得到研究。本研究增加了什么?本研究显示了HECSI良好的反应性。提出了单个评分的严重程度分级。确定了改善的最小可检测变化和最小重要变化。这项工作的临床意义是什么?获得的值有助于在日常实践和临床研究中解释HECSI评分,并可能有助于研究人员计算临床试验的样本量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/6b752135f320/BJD-182-932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/554898257611/BJD-182-932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/57c9c5f7bf1d/BJD-182-932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/6b752135f320/BJD-182-932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/554898257611/BJD-182-932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/57c9c5f7bf1d/BJD-182-932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3f/7186841/6b752135f320/BJD-182-932-g003.jpg

相似文献

1
Responsiveness and interpretability of the Hand Eczema Severity Index.手部湿疹严重程度指数的反应性与可解释性。
Br J Dermatol. 2020 Apr;182(4):932-939. doi: 10.1111/bjd.18295. Epub 2019 Sep 5.
2
New evidence on the minimal important change (MIC) for the Hand Eczema Severity Index (HECSI).手部湿疹严重程度指数(HECSI)最小重要变化(MIC)的新证据。
Contact Dermatitis. 2021 Mar 3. doi: 10.1111/cod.13828.
3
Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ).荷兰手部湿疹生活质量问卷(QOLHEQ)的验证
Br J Dermatol. 2020 Jul;183(1):86-95. doi: 10.1111/bjd.18558. Epub 2019 Nov 24.
4
The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.特应性皮炎 RECAP 问卷的构建效度、反应度、信度和可解释性在儿童中的研究。
Br J Dermatol. 2024 May 17;190(6):867-875. doi: 10.1093/bjd/ljae017.
5
Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.特应性皮炎简明问卷(RECAP)的有效性、信度、反应度和可诠释性。
Br J Dermatol. 2023 Oct 25;189(5):578-587. doi: 10.1093/bjd/ljad247.
6
Interpretability of the Quality Of Life in Hand Eczema Questionnaire.手部湿疹生活质量问卷的可解释性。
J Invest Dermatol. 2020 Apr;140(4):785-790. doi: 10.1016/j.jid.2019.08.450. Epub 2019 Oct 10.
7
Assessment of hand eczema severity by patients using the hand eczema severity index (HECSI).患者使用手部湿疹严重指数(HECSI)评估手部湿疹严重程度。
J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2349-2354. doi: 10.1111/jdv.19329. Epub 2023 Jul 24.
8
Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials.乌帕替尼治疗中重度特应性皮炎患者特应性手部湿疹的效果:两项随机 3 期临床试验结果。
J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1863-1870. doi: 10.1111/jdv.19194. Epub 2023 Jun 1.
9
Photographic Documentation and Hand Eczema Severity Index for Severity Assessment of Hand Eczema.用于手部湿疹严重程度评估的摄影记录和手部湿疹严重程度指数
Dermatitis. 2017 Jul/Aug;28(4):280-283. doi: 10.1097/DER.0000000000000306.
10
Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions.手部湿疹严重程度指数(HECSI)的效度、信度及检测变化能力评估,以及将HECSI-75和HECSI-90作为患者内缓解定义的评估。
Contact Dermatitis. 2025 Jan;92(1):51-60. doi: 10.1111/cod.14699. Epub 2024 Oct 13.

引用本文的文献

1
The Prevalence and Severity of Hand Eczema Among Adults in Tasiilaq, East Greenland.东格陵兰塔西拉克成年人手部湿疹的患病率及严重程度
Contact Dermatitis. 2025 Jul;93(1):49-55. doi: 10.1111/cod.14781. Epub 2025 Mar 5.
2
Baricitinib in severe and recalcitrant hyperkeratotic chronic hand eczema and associated tissue cytokine patterns: are pan JAK inhibitors a more suitable choice?巴瑞替尼治疗重度顽固性角化过度型慢性手部湿疹及相关组织细胞因子模式:泛JAK抑制剂是否是更合适的选择?
Arch Dermatol Res. 2025 Feb 20;317(1):443. doi: 10.1007/s00403-025-03980-y.
3
Italian Expert Opinion on Chronic Hand Eczema: from Guidelines to Clinical Practice.

本文引用的文献

1
Which outcomes have been measured in hand eczema trials? A systematic review.手部湿疹临床试验中测量了哪些结局?一项系统评价。
Contact Dermatitis. 2019 Apr;80(4):201-207. doi: 10.1111/cod.13212. Epub 2019 Feb 22.
2
Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.研究方案:口服阿利维A酸与口服环孢素A治疗重度复发性水疱型手部湿疹患者的疗效比较(ALICsA):一项采用盲法结局评估的随机前瞻性开放标签试验。
BMJ Open. 2018 Jul 11;8(7):e020192. doi: 10.1136/bmjopen-2017-020192.
3
意大利慢性手部湿疹专家意见:从指南到临床实践
Dermatol Ther (Heidelb). 2025 Jan;15(1):75-93. doi: 10.1007/s13555-024-01312-y. Epub 2024 Nov 28.
4
Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions.手部湿疹严重程度指数(HECSI)的效度、信度及检测变化能力评估,以及将HECSI-75和HECSI-90作为患者内缓解定义的评估。
Contact Dermatitis. 2025 Jan;92(1):51-60. doi: 10.1111/cod.14699. Epub 2024 Oct 13.
5
Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT.阿利维 A 酸酯与光疗作为成人重度慢性手部湿疹一线治疗的比较:ALPHA RCT。
Health Technol Assess. 2024 Oct;28(59):1-123. doi: 10.3310/TWQC0141.
6
Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment.外用糖皮质激素治疗2周后手部湿疹与皮肤微生物群的变化
J Eur Acad Dermatol Venereol. 2025 Jun;39(6):1118-1125. doi: 10.1111/jdv.20366. Epub 2024 Oct 3.
7
Psychosocial Consequences of Hand Eczema-A Prospective Cross-Sectional Study.手部湿疹的心理社会后果——一项前瞻性横断面研究
J Clin Med. 2023 Sep 3;12(17):5741. doi: 10.3390/jcm12175741.
8
Prevalence and Characteristics of Itch and Pain in Patients Suffering from Chronic Hand Eczema.慢性手部湿疹患者瘙痒和疼痛的患病率及特征
J Clin Med. 2023 Jun 21;12(13):4198. doi: 10.3390/jcm12134198.
9
Pediatric chronic hand eczema: Epidemiology, clinical presentation, and management.小儿慢性手部湿疹:流行病学、临床表现及管理
JAAD Int. 2023 Feb 27;11:165-173. doi: 10.1016/j.jdin.2023.02.008. eCollection 2023 Jun.
10
[New guideline and treatment options for hand eczema].[手部湿疹的新指南及治疗选择]
Dermatologie (Heidelb). 2023 Jun;74(6):425-429. doi: 10.1007/s00105-023-05143-4. Epub 2023 May 24.
3 steps to improve reporting and interpretation of patient-reported outcome scores in orthopedic studies.
改善骨科研究中患者报告结局评分报告与解读的三个步骤。
Acta Orthop. 2018 Feb;89(1):1-2. doi: 10.1080/17453674.2017.1407058. Epub 2017 Nov 27.
4
Guidelines for diagnosis, prevention and treatment of hand eczema.手部湿疹的诊断、预防和治疗指南。
J Dtsch Dermatol Ges. 2015 Jan;13(1):e1-22. doi: 10.1111/ddg.12510_1.
5
What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.特应性皮炎严重程度的湿疹面积和严重程度指数评分告诉了我们什么:一项可解释性研究。
Br J Dermatol. 2015;172(5):1353-7. doi: 10.1111/bjd.13662. Epub 2015 Apr 16.
6
Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention.测量工具的最小重要变化值更多地取决于基线值,而不是干预类型。
J Clin Epidemiol. 2015 May;68(5):518-24. doi: 10.1016/j.jclinepi.2014.07.008. Epub 2014 Nov 26.
7
Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.根据基于锚定的方法得出的严重程度分层建议,将以患者为中心的湿疹量表 (POEM) 评分转化为临床实践。
Br J Dermatol. 2013 Dec;169(6):1326-32. doi: 10.1111/bjd.12590.
8
EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference.EASI、SCORAD 和 POEM 用于特应性皮炎:反应性和最小临床重要差异。
Allergy. 2012 Jan;67(1):99-106. doi: 10.1111/j.1398-9995.2011.02719.x. Epub 2011 Sep 27.
9
Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema.基于丹麦手部湿疹诊断和治疗指南的手部湿疹指南。
Contact Dermatitis. 2011 Jul;65(1):3-12. doi: 10.1111/j.1600-0536.2011.01915.x.
10
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.COSMIN 研究就健康相关患者报告结局的测量属性的分类学、术语和定义达成了国际共识。
J Clin Epidemiol. 2010 Jul;63(7):737-45. doi: 10.1016/j.jclinepi.2010.02.006.